Clinical Trial Supplies Companies

The global clinical trial supplies market is anticipated to reach USD 8.18 billion in 2030 from USD 5.34 billion in 2025, with a significant CAGR of 8.9%. The market for clinical trial supplies market is competitive, with key players strategizing to capture the majority of market share.

Prominent players in the clinical trial supplies market are Thermo Fisher Scientific Inc. (US), Novo Holdings A/S (Denmark), Almac Group (UK), United Parcel Service of America, Inc. (US) and Eurofins Scientific (Germany), among others. The key market players adopt various growth strategies, such as organic and inorganic, that include partnerships, agreements, expansions, and acquisitions to strengthen their position in the clinical trial supplies market.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific Inc. (US) is one of the dominant players in the clinical trial supplies market.  Thermo Fisher operates 27 purpose-built GMP/GDP-compliant facilities, complemented by over 40 partner depots across five continents. This extensive infrastructure ensures regulatory-compliant movement, management, and delivery of supplies to more than 150 countries, supporting diverse therapeutic areas. The company operates in the clinical trial supplies market through its subsidiary Patheon. The company strongly focuses on organic and inorganic growth strategies to maintain a leading market position. The company offers end-to-end clinical supply services, including manufacturing, packaging, labeling, storage, distribution, and comparator sourcing.

Novo Holdings A/S (Denmark) is one of the leading players in the clinical trial supplies market. The company operates in the market through Catalent.  Catalent is a leading CDMO (Contract Development & Manufacturing Organization) with expertise in biologics, gene therapy, and small molecule drug development. Catalent operates eight facilities across the US, EU, and Asia/Pacific regions, complemented by a network of over 50 depots spanning six continents. This extensive infrastructure ensures efficient management and distribution of clinical supplies worldwide. Catalent has invested in expanding its facilities to meet increasing demands. For instance, the company initiated a USD 20 million expansion of its clinical supply facility in Schorndorf, Germany.

Market Ranking

The clinical trial supplies (HCS) market is highly competitive, with five main players collectively holding 40-50% of the total market share. The clinical trial supplies services market is led by key players that provide essential support for pharmaceutical and biotechnology companies during clinical trials. Thermo Fisher Scientific Inc. is a major provider of drug development tools and services, benefiting from increased demand. Almac Group offers comprehensive clinical trial supply, manufacturing, and packaging solutions. Catalent Inc. specializes in advanced delivery technologies, development, and manufacturing solutions for drugs and biologics.

The remaining 60-70% of the market is shared among other regional and emerging vendors, contributing to extensive fragmentation and offering opportunities for smaller players to establish a footprint. Market competition is driven by several key factors, including technological advancements, product innovation, strategic collaborations, and increasing demand from pharmaceutical and biotechnology companies.

Related Reports:

Clinical Trial Supplies Market by Services (Manufacturing, Sourcing, Packaging, Labelling, Logistics), Phases, Type (Small Molecules, Biologics, Vaccines), Therapeutic Areas (Oncology, Neurology, CVD, Ophthalmology, Dermatology) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]